These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33362770)

  • 21. Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week.
    Ridker PM
    J Am Coll Cardiol; 2018 Dec; 72(25):3320-3331. PubMed ID: 30415883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy for cardiovascular disease.
    Lutgens E; Atzler D; Döring Y; Duchene J; Steffens S; Weber C
    Eur Heart J; 2019 Dec; 40(48):3937-3946. PubMed ID: 31121017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.
    Cabrera SM; Wang X; Chen YG; Jia S; Kaldunski ML; Greenbaum CJ; ; Mandrup-Poulsen T; ; Hessner MJ
    Eur J Immunol; 2016 Apr; 46(4):1030-46. PubMed ID: 26692253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
    Voronov E; Apte RN
    Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β.
    Lacy SE; Wu C; Ambrosi DJ; Hsieh CM; Bose S; Miller R; Conlon DM; Tarcsa E; Chari R; Ghayur T; Kamath RV
    MAbs; 2015; 7(3):605-19. PubMed ID: 25764208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.
    Woo J; Lu D; Lewandowski A; Xu H; Serrano P; Healey M; Yates DP; Beste MT; Libby P; Ridker PM; Steensma DP
    Blood Adv; 2023 Dec; 7(24):7471-7484. PubMed ID: 37934948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Interleukin-1β Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
    Vallurupalli M; MacFadyen JG; Glynn RJ; Thuren T; Libby P; Berliner N; Ridker PM
    Ann Intern Med; 2020 Apr; 172(8):523-532. PubMed ID: 32203978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Future of IL-1 Targeting in Kidney Disease.
    Afsar B; Covic A; Ortiz A; Afsar RE; Kanbay M
    Drugs; 2018 Jul; 78(11):1073-1083. PubMed ID: 29968152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.
    Choudhury RP; Birks JS; Mani V; Biasiolli L; Robson MD; L'Allier PL; Gingras MA; Alie N; McLaughlin MA; Basson CT; Schecter AD; Svensson EC; Zhang Y; Yates D; Tardif JC; Fayad ZA
    J Am Coll Cardiol; 2016 Oct; 68(16):1769-1780. PubMed ID: 27737744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CANTOS - is selective targeting of inflammation in atherosclerosis enough?
    Misra DP; Agarwal V
    J R Coll Physicians Edinb; 2018 Sep; 48(3):246-247. PubMed ID: 30191914
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutting Edge: IL-1α and Not IL-1β Drives IL-1R1-Dependent Neonatal Murine Sepsis Lethality.
    Benjamin JT; Moore DJ; Bennett C; van der Meer R; Royce A; Loveland R; Wynn JL
    J Immunol; 2018 Nov; 201(10):2873-2878. PubMed ID: 30305325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
    Libby P
    J Am Coll Cardiol; 2017 Oct; 70(18):2278-2289. PubMed ID: 29073957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of both IL-1α/IL-1β plays a major role in suppressing combined cigarette smoke/virus-induced pulmonary inflammation in mice.
    Bucher H; Mang S; Keck M; Przibilla M; Lamb DJ; Schiele F; Wittenbrink M; Fuchs K; Jung B; Erb KJ; Peter D
    Pulm Pharmacol Ther; 2017 Jun; 44():96-105. PubMed ID: 28315490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inflammation and atherosclerosis – last piece of the puzzle has fallen into place].
    Jonasson L; Hansson G
    Lakartidningen; 2017 Oct; 114():. PubMed ID: 29292899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct contributions of interleukin-1α (IL-1α) and IL-1β to innate immune recognition of Pseudomonas aeruginosa in the lung.
    Al Moussawi K; Kazmierczak BI
    Infect Immun; 2014 Oct; 82(10):4204-11. PubMed ID: 25069982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.
    Fettelschoss A; Kistowska M; LeibundGut-Landmann S; Beer HD; Johansen P; Senti G; Contassot E; Bachmann MF; French LE; Oxenius A; Kündig TM
    Proc Natl Acad Sci U S A; 2011 Nov; 108(44):18055-60. PubMed ID: 22006336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging Anti-Atherosclerotic Therapies.
    Gluba-Brzózka A; Franczyk B; Rysz-Górzyńska M; Ławiński J; Rysz J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-1β in atherosclerotic vascular calcification: From bench to bedside.
    Shen J; Zhao M; Zhang C; Sun X
    Int J Biol Sci; 2021; 17(15):4353-4364. PubMed ID: 34803503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine: an affordable anti-inflammatory agent for atherosclerosis.
    Thompson PL; Nidorf SM
    Curr Opin Lipidol; 2018 Dec; 29(6):467-473. PubMed ID: 30320614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.